Spatiotemporal Strategies for Lipid-Based Nanocarriers in Stroke

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Neuroscience

Background:

• Stroke is a major cause of disability with limited neuroprotective and regenerative therapies.
• Current reperfusion strategies have narrow therapeutic windows and risks of injury.
• There is a critical need for advanced neuroprotective and regenerative approaches in stroke management.

Purpose of the Study:

• To review lipid-based nanocarriers for spatiotemporal drug delivery in stroke therapy.
• To explore their potential for blood-brain barrier penetration, inflammation modulation, and neural regeneration.
• To provide guidance for future translational efforts in stroke treatment.

Main Methods:

• Comprehensive literature review of lipid-based nanocarriers in stroke therapy.
• Analysis of spatiotemporal drug delivery strategies across acute, subacute, and recovery stroke phases.
• Discussion of challenges and opportunities for clinical translation.

Main Results:

• Lipid-based nanocarriers show promise for targeted drug delivery across different stroke phases.
• These nanocarriers can potentially enhance blood-brain barrier penetration, modulate inflammation, and promote neural regeneration.
• The chemical design of nanocarriers is crucial for optimizing therapeutic outcomes.

Conclusions:

• Lipid-based nanocarriers represent a promising platform for advanced stroke therapies.
• Standardization of formulation and overcoming clinical translation barriers are essential next steps.
• Further research into nanocarrier chemical design will optimize efficacy for neuroprotection and regeneration in stroke.